Engeli Stefan, Boschmann Michael, Adams Frauke, Franke Gabriele, Gorzelniak Kerstin, Janke Jürgen, Luft Friedrich C, Jordan Jens
Franz-Volhard Clinical Research Center, Charité Campus Buch, Wiltbergstrasse 50, 13125 Berlin, Germany.
J Clin Endocrinol Metab. 2007 Jul;92(7):2706-11. doi: 10.1210/jc.2007-0234. Epub 2007 Apr 24.
Nitric oxide synthase (NOS) expression in adipose tissue is increased in obese subjects. The functional relevance is not known.
The objective was to compare adipose tissue metabolism between obese men with greater or lower adipose endothelial NOS (eNOS) or inducible NOS (iNOS) expression.
The design was an open-labeled prospective study.
The study took place at an academic clinical research center.
The patients included 14 obese (32 +/- 0.6 kg/m2) and eight normal-weight (23 +/- 2 kg/m2) healthy men.
Microdialysis catheters in abdominal sc adipose tissue and in vastus lateralis were perfused with N-omega-nitro-L-arginine methyl ester (L-NAME) or N-omega-nitro-D-arginine methyl ester (D-NAME). Then, incremental isoproterenol concentrations were added to the perfusate.
Microdialysate glycerol was the main outcome measure.
Tissue perfusion and microdialysate glycerol concentrations at baseline and during isoproterenol stimulation were similar in obese men with high or low eNOS or iNOS expression during both L-NAME and D-NAME. During D-NAME, basal and maximal isoproterenol stimulated glycerol were similar in lean and in obese men. However, in lean men, the dose-response relationship between isoproterenol and glycerol was shifted towards the left (P < 0.0001). NOS inhibition with L-NAME had no effect on basal or isoproterenol-stimulated glycerol in the obese group in skeletal muscle or in adipose tissue. In contrast, L-NAME augmented the lipolytic response in lean subjects in both tissues.
Differences in eNOS and iNOS mRNA expression at the adipose tissue level may have a limited effect on lipolysis and tissue perfusion. The lower resting lipolysis in adipose tissue of obese compared with nonobese subjects cannot be explained by a tonic nitric oxide effect.
肥胖受试者脂肪组织中一氧化氮合酶(NOS)表达增加。其功能相关性尚不清楚。
比较脂肪内皮型NOS(eNOS)或诱导型NOS(iNOS)表达较高或较低的肥胖男性之间的脂肪组织代谢。
开放标签前瞻性研究。
研究在学术临床研究中心进行。
患者包括14名肥胖(32±0.6kg/m²)和8名正常体重(23±2kg/m²)的健康男性。
在腹部皮下脂肪组织和股外侧肌中植入微透析导管,用N-ω-硝基-L-精氨酸甲酯(L-NAME)或N-ω-硝基-D-精氨酸甲酯(D-NAME)进行灌注。然后,向灌注液中添加递增浓度的异丙肾上腺素。
微透析液甘油是主要观察指标。
在L-NAME和D-NAME期间,eNOS或iNOS表达高或低的肥胖男性在基线时以及异丙肾上腺素刺激期间的组织灌注和微透析液甘油浓度相似。在D-NAME期间,瘦人和肥胖男性的基础和最大异丙肾上腺素刺激甘油相似。然而,在瘦人中,异丙肾上腺素与甘油之间的剂量反应关系向左偏移(P<0.0001)。L-NAME抑制NOS对肥胖组骨骼肌或脂肪组织中的基础或异丙肾上腺素刺激甘油无影响。相反,L-NAME增强了瘦人在两个组织中的脂解反应。
脂肪组织水平的eNOS和iNOS mRNA表达差异可能对脂解和组织灌注影响有限。肥胖受试者脂肪组织中较低的静息脂解不能用一氧化氮的张力效应来解释。